Juan J Calvete Selected Research

Snake Bites (Snake Bite)

7/2021	Mutual enlightenment: A toolbox of concepts and methods for integrating evolutionary and clinical toxinology via snake venomics and the contextual stance.
1/2021	Antivenomics and in vivo preclinical efficacy of six Latin American antivenoms towards south-western Colombian Bothrops asper lineage venoms.
1/2020	Venomics and antivenomics of the poorly studied Brazil's lancehead, Bothrops brazili (Hoge, 1954), from the Brazilian State of Pará.
1/2020	Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite.
1/2019	New insights into the phylogeographic distribution of the 3FTx/PLA2 venom dichotomy across genus Micrurus in South America.
1/2019	Phylovenomics of Daboia russelii across the Indian subcontinent. Bioactivities and comparative in vivo neutralization and in vitro third-generation antivenomics of antivenoms against venoms from India, Bangladesh and Sri Lanka.
6/2018	Toxin-resolved antivenomics-guided assessment of the immunorecognition landscape of antivenoms.
1/2018	A synthetic biology approach for consistent production of plant-made recombinant polyclonal antibodies against snake venom toxins.
1/2018	The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms.
10/2017	Third Generation Antivenomics: Pushing the Limits of the In Vitro Preclinical Assessment of Antivenoms.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juan J Calvete Research Topics

Disease

34	Snake Bites (Snake Bite) 07/2021 - 11/2007
9	Bites and Stings (Sting) 01/2020 - 08/2008
8	Myotoxicity 10/2014 - 10/2008
6	Neoplasms (Cancer) 06/2020 - 05/2003
5	Hemorrhage 01/2020 - 02/2010
5	Edema (Dropsy) 01/2017 - 10/2008
4	Necrosis 09/2013 - 02/2010
3	Adenocarcinoma of Lung 06/2020 - 09/2013
3	Respiratory Paralysis 01/2019 - 08/2011
2	Adenocarcinoma 06/2020 - 01/2014
2	Paralysis (Palsy) 01/2020 - 01/2019
2	Pain (Aches) 01/2020 - 08/2019
2	Glioma (Gliomas) 06/2015 - 05/2013
2	Melanoma (Melanoma, Malignant) 12/2014 - 08/2009
2	Neglected Diseases 01/2014 - 08/2011
2	Thrombosis (Thrombus) 04/2012 - 08/2006
1	Type 2 Diabetes Mellitus (MODY) 06/2020
1	Shock 01/2020
1	Unconsciousness (Loss of Consciousness) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Hypotension (Low Blood Pressure) 01/2020
1	Disseminated Intravascular Coagulation 04/2017
1	Hemolysis 01/2017
1	Myocardial Infarction 02/2013
1	Gangrene 11/2011
1	Neuroblastoma 11/2009
1	Neoplasm Metastasis (Metastasis) 08/2009
1	Wounds and Injuries (Trauma) 09/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2007
1	Newborn Respiratory Distress Syndrome 04/2006
1	Autoimmune Diseases (Autoimmune Disease) 04/2006
1	Liver Diseases (Liver Disease) 05/2004
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2004

Drug/Important Bio-Agent (IBA)

39	VenomsIBA 06/2020 - 11/2007
28	Antivenins (Antivenoms)IBA 01/2021 - 08/2008
7	Snake Venoms (Snake Venom)IBA 01/2018 - 02/2008
6	Proteins (Proteins, Gene)FDA Link 06/2020 - 05/2004
4	Biological ProductsIBA 07/2021 - 01/2015
4	EnzymesIBA 01/2018 - 02/2012
4	CoagulantsIBA 01/2017 - 10/2008
3	Peptides (Polypeptides)IBA 06/2020 - 01/2014
3	NeurotoxinsIBA 01/2019 - 08/2011
3	DisintegrinsIBA 12/2014 - 01/2007
3	CollagenIBA 05/2013 - 04/2006
2	Serine Proteases (Serine Protease)IBA 06/2016 - 09/2002
2	Metalloproteases (Metalloproteinases)IBA 04/2015 - 07/2012
2	Laminin (Merosin)IBA 04/2015 - 12/2014
2	Fibronectins (Fibronectin)IBA 12/2014 - 05/2013
2	Three Finger ToxinsIBA 10/2014 - 08/2011
2	IntegrinsIBA 02/2013 - 01/2007
2	Phospholipases AIBA 02/2012 - 03/2010
2	Integrin alpha1beta1IBA 08/2009 - 05/2003
1	Phospholipases A2 (Phospholipase A2)IBA 06/2020
1	Glucose (Dextrose)FDA LinkGeneric 06/2020
1	Insulin (Novolin)FDA Link 06/2020
1	Protein Isoforms (Isoforms)IBA 06/2020
1	Chelating AgentsIBA 01/2020
1	L-Amino Acid OxidaseIBA 01/2020
1	Unithiol (DMPS)IBA 01/2020
1	Factor X (Stuart Factor)IBA 01/2020
1	Thrombin FDA Link 01/2020
1	MetalsIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	ProteomeIBA 01/2020
1	AcidsIBA 08/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2019
1	TrypsinIBA 06/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2015
1	nidogen (entactin)IBA 04/2015
1	Collagen Type IV (Type IV Collagen)IBA 04/2015
1	Collagen Type VIIBA 04/2015
1	Extracellular Matrix ProteinsIBA 12/2014
1	Collagen Type I (Type I Collagen)IBA 12/2014
1	VitronectinIBA 12/2014
1	Elapid Venoms (Cobra Venom)IBA 10/2014
1	AntibodiesIBA 01/2014
1	snake venom neurotoxin FIBA 01/2014
1	AnticoagulantsIBA 10/2013
1	ZincIBA 07/2012
1	batimastat (BB 94)IBA 07/2012
1	Prothrombin (Factor II)IBA 04/2012
1	SolutionsIBA 08/2011
1	Cytotoxins (Cytolysins)IBA 03/2011
1	Toxic ActionsIBA 03/2010
1	Immunoglobulin G (IgG)IBA 02/2010
1	RNA Precursors (Precursor, mRNA)IBA 11/2009
1	Nuclear Proteins (Protein, Nuclear)IBA 11/2009
1	Integrin alpha2beta1IBA 08/2009
1	Collagen ReceptorsIBA 08/2009
1	Phospholipases (Phospholipase)IBA 10/2008
1	Membrane LipidsIBA 09/2007
1	Malondialdehyde (Propanedial)IBA 09/2007
1	Integrin alpha ChainsIBA 01/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2007
1	CarboxypeptidasesIBA 08/2006
1	DisulfidesIBA 08/2006
1	Surface-Active Agents (Surfactants)IBA 04/2006

Therapy/Procedure

6	Therapeutics 06/2020 - 04/2007
1	Complementary Therapies (Alternative Medicine) 01/2018
1	Intravenous Injections 01/2017